<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02582151</url>
  </required_header>
  <id_info>
    <org_study_id>107210</org_study_id>
    <nct_id>NCT02582151</nct_id>
  </id_info>
  <brief_title>Transcutaneous Peripheral Neuromodulation for Neurogenic Bladder</brief_title>
  <official_title>A Randomized Trial of Transcutaneous Nerve Stimulation for Neurogenic Bladder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neurogenic bladder patients may have symptoms of urinary frequency, urgency, urgency
      incontinence and voiding symptoms due to bladder dysfunction arising from their underlying
      neurologic condition. Current treatment options are effective for some patients, however many
      patients are not optimally managed due to modest efficacy or significant side effects. Second
      line therapies include intravesical onabotulinum toxin, however it is associated with a risk
      of urinary retention, and patients with neurologic disorders often are unable to perform self
      catheterize due to physical limitations. Sacral neuromodulation is associated with an
      undesirably high cost and potential complications in this population. The use of
      transcutaneous tibial nerve stimulation is an alternative form of neuromodulation, and it may
      have some potential benefits over percutaneous tibial nerve stimulation. While some
      preliminary studies have suggested it may be effective, there are no high quality randomized
      trials. This proposal is a 3 month, randomized, sham-controlled, clinical trial to evaluate
      the short term clinical efficacy of at home transcutaneous tibial nerve stimulation. Valid
      and reliable patient reported outcome measures, and objective measures of incontinence have
      been included as outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Actual">April 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Perception of Bladder Condition Questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>Patient perception of bladder condition (PPBC) question. It is scored from 0 (My bladder condition does not cause me any problems at all) to 5 (My bladder condition causes me many severe problems). Higher numbers are worse outcomes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurogenic Bladder Symptom Score (NBSS) Questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>The NBSS is a patient reported symptom score covering three domains: incontinence, storage/voiding, and consequences. It is scored from 0 to 72, and a higher score is worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qualiveen-Short Form Questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>Patient reported questionnaire that measures quality of life among neurogenic bladder patients. Score ranges from 0 to 32. A higher score is worse.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3-day Voiding Diary</measure>
    <time_frame>3 months</time_frame>
    <description>Daily urinary frequency as recorded by the patient over 3 days. Summarised as an average daily frequency.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24hr Incontinence Pad Weights</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician Assessment of Patient Benefit (Global Response Scale)</measure>
    <time_frame>3 months</time_frame>
    <description>Completed by physicians based on their assessment after discussion with the patient as to the amount of benefit they received. Reported on a scale of 0 (no benefit) to 7 (substantial benefit)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Urinary Bladder, Neurogenic</condition>
  <arm_group>
    <arm_group_label>Sham tibial nerve stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Use of peripheral nerve stimulator in a location that will not actively stimulate the tibial nerve.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tibial nerve stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transcutaneous peripheral nerve stimulator in a location that will actively stimulate the tibial nerve.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine</intervention_name>
    <description>Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
    <arm_group_label>Sham tibial nerve stimulation</arm_group_label>
    <arm_group_label>Tibial nerve stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. &gt;18 years of age, with a clinical condition associated with neurogenic bladder
             dysfunction (multiple sclerosis, Parkinson's disease, stroke, dementia, cerebral
             palsy, spinal cord injury)(27).

          2. Failure of behavioral measures and/or pharmacologic therapy to adequately control
             neurogenic bladder symptoms.

        Exclusion Criteria:

          1. Current or previous percutaneous/transcutaneous tibial nerve stimulation or sacral
             neuromodulation therapy

          2. Stress predominant urinary incontinence

          3. Newly added bladder medication or dose change with the last 2 months (Tamsulosin,
             Silodosin, Alfuzosin, Terazosin, Baclofen, Diazepam, amitriptyline, imipramine, DDAVP,
             tolterodine, oxybutynin, fesoterodine, darifenacin, solifenacin, trospium, mirabegron)

          4. Intravesical botulinum toxin use within the last 1 year

          5. Implanted pacemaker or defibrillator

          6. History of epilepsy

          7. Unable or unwilling to commit to study treatment schedule

          8. Pregnant, or possible pregnancy planned for the duration of the study period

          9. Active skin disease of the lower legs (dermatitis, cellulitis, eczema, trauma)

         10. Documented allergy to patch electrodes or their adhesive

         11. Metallic implant within the lower limb
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 13, 2015</study_first_submitted>
  <study_first_submitted_qc>October 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2015</study_first_posted>
  <results_first_submitted>September 11, 2019</results_first_submitted>
  <results_first_submitted_qc>January 6, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 9, 2020</results_first_posted>
  <last_update_submitted>January 6, 2020</last_update_submitted>
  <last_update_submitted_qc>January 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder, Neurogenic</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 1, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/51/NCT02582151/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sham Tibial Nerve Stimulation</title>
          <description>Use of peripheral nerve stimulator in a location that will not actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
        </group>
        <group group_id="P2">
          <title>Tibial Nerve Stimulation</title>
          <description>Transcutaneous peripheral nerve stimulator in a location that will actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sham Tibial Nerve Stimulation</title>
          <description>Use of peripheral nerve stimulator in a location that will not actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
        </group>
        <group group_id="B2">
          <title>Tibial Nerve Stimulation</title>
          <description>Transcutaneous peripheral nerve stimulator in a location that will actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53" lower_limit="44" upper_limit="60"/>
                    <measurement group_id="B2" value="60" lower_limit="49" upper_limit="65"/>
                    <measurement group_id="B3" value="56" lower_limit="47" upper_limit="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patient Perception of Bladder Condition Questionnaire</title>
        <description>Patient perception of bladder condition (PPBC) question. It is scored from 0 (My bladder condition does not cause me any problems at all) to 5 (My bladder condition causes me many severe problems). Higher numbers are worse outcomes.</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham Tibial Nerve Stimulation</title>
            <description>Use of peripheral nerve stimulator in a location that will not actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Stimulation</title>
            <description>Transcutaneous peripheral nerve stimulator in a location that will actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Perception of Bladder Condition Questionnaire</title>
          <description>Patient perception of bladder condition (PPBC) question. It is scored from 0 (My bladder condition does not cause me any problems at all) to 5 (My bladder condition causes me many severe problems). Higher numbers are worse outcomes.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="3" upper_limit="3"/>
                    <measurement group_id="O2" value="3" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neurogenic Bladder Symptom Score (NBSS) Questionnaire</title>
        <description>The NBSS is a patient reported symptom score covering three domains: incontinence, storage/voiding, and consequences. It is scored from 0 to 72, and a higher score is worse outcome.</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham Tibial Nerve Stimulation</title>
            <description>Use of peripheral nerve stimulator in a location that will not actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Stimulation</title>
            <description>Transcutaneous peripheral nerve stimulator in a location that will actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
        </group_list>
        <measure>
          <title>Neurogenic Bladder Symptom Score (NBSS) Questionnaire</title>
          <description>The NBSS is a patient reported symptom score covering three domains: incontinence, storage/voiding, and consequences. It is scored from 0 to 72, and a higher score is worse outcome.</description>
          <units>Units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33" lower_limit="29" upper_limit="38"/>
                    <measurement group_id="O2" value="29" lower_limit="25" upper_limit="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Qualiveen-Short Form Questionnaire</title>
        <description>Patient reported questionnaire that measures quality of life among neurogenic bladder patients. Score ranges from 0 to 32. A higher score is worse.</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham Tibial Nerve Stimulation</title>
            <description>Use of peripheral nerve stimulator in a location that will not actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Stimulation</title>
            <description>Transcutaneous peripheral nerve stimulator in a location that will actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
        </group_list>
        <measure>
          <title>Qualiveen-Short Form Questionnaire</title>
          <description>Patient reported questionnaire that measures quality of life among neurogenic bladder patients. Score ranges from 0 to 32. A higher score is worse.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="23" upper_limit="31"/>
                    <measurement group_id="O2" value="27" lower_limit="24" upper_limit="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>3-day Voiding Diary</title>
        <description>Daily urinary frequency as recorded by the patient over 3 days. Summarised as an average daily frequency.</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham Tibial Nerve Stimulation</title>
            <description>Use of peripheral nerve stimulator in a location that will not actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Stimulation</title>
            <description>Transcutaneous peripheral nerve stimulator in a location that will actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
        </group_list>
        <measure>
          <title>3-day Voiding Diary</title>
          <description>Daily urinary frequency as recorded by the patient over 3 days. Summarised as an average daily frequency.</description>
          <units>voids per 24 hrs</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="8" upper_limit="11"/>
                    <measurement group_id="O2" value="9" lower_limit="7" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>24hr Incontinence Pad Weights</title>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham Tibial Nerve Stimulation</title>
            <description>Use of peripheral nerve stimulator in a location that will not actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Stimulation</title>
            <description>Transcutaneous peripheral nerve stimulator in a location that will actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
        </group_list>
        <measure>
          <title>24hr Incontinence Pad Weights</title>
          <units>grams</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="364" lower_limit="333" upper_limit="395"/>
                    <measurement group_id="O2" value="362" lower_limit="334" upper_limit="391"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Physician Assessment of Patient Benefit (Global Response Scale)</title>
        <description>Completed by physicians based on their assessment after discussion with the patient as to the amount of benefit they received. Reported on a scale of 0 (no benefit) to 7 (substantial benefit)</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham Tibial Nerve Stimulation</title>
            <description>Use of peripheral nerve stimulator in a location that will not actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Stimulation</title>
            <description>Transcutaneous peripheral nerve stimulator in a location that will actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
          </group>
        </group_list>
        <measure>
          <title>Physician Assessment of Patient Benefit (Global Response Scale)</title>
          <description>Completed by physicians based on their assessment after discussion with the patient as to the amount of benefit they received. Reported on a scale of 0 (no benefit) to 7 (substantial benefit)</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="3" upper_limit="3"/>
                    <measurement group_id="O2" value="3" lower_limit="2" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>10 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Sham Tibial Nerve Stimulation</title>
          <description>Use of peripheral nerve stimulator in a location that will not actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
        </group>
        <group group_id="E2">
          <title>Tibial Nerve Stimulation</title>
          <description>Transcutaneous peripheral nerve stimulator in a location that will actively stimulate the tibial nerve.
EV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machine: Percutaneous patch electrodes are used to deliver low level electrical currents.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Blayne Welk</name_or_title>
      <organization>Lawson Health Research</organization>
      <phone>5196466000</phone>
      <email>lawson@lawsonresearch.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

